Conclusions and implications

Social Science and Medicine

Volumn 45, Issue 4, 1997, Pages 645-647

  Sloan, Frank A ^a   Grabowski, Henry G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DECISION MAKING; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; SHORT SURVEY;

EID: 0030857661     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0277-9536(97)81011-8     Document Type: Article

References (2)

1. Mullahy, J. and Manning, W. (1995) Statistical issues in cost-effective analyses. In Valuing Health Care: Costs, Benefits, and Effectiveness of Pharmaceuticals and Other Medical Technologies, ed. F. Sloan, pp. 149-84. Cambridge University Press, New York.
2. U.S. Food and Drug Administration (1995) Principles for the Review of Pharmacoeconomic Promotion. Draft Guidelines. U.S. Food and Drug Administration, Washington, DC.